Floatz logo

Therapeutic Asset Ratings

3,272 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Sirolimus
B-Cell Adult Acute Lymphocytic Leukemia
National Cancer Institute (NCI)P2CCC (53)
Sirolimus
B-Cell Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)P2CCC (53)
Sirolimus
T-Cell Adult Acute Lymphocytic Leukemia
National Cancer Institute (NCI)P2CCC (53)
Sleeping Beauty Transposed Pbl
Neuroendocrine Neoplasm
National Cancer Institute (NCI)P2CCC (53)
Sotorasib
Breast Cancer
National Cancer Institute (NCI)P2CCC (53)
Sotorasib
Female Reproductive Organ Cancer
National Cancer Institute (NCI)P2CCC (53)
Sotorasib
Her2-Receptor Negative Breast Cancer
National Cancer Institute (NCI)P2CCC (53)
Sotorasib
Endometrial Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Sotorasib
Fallopian Tube Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Sotorasib
Ovarian Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Sotorasib
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Tacrolimus
B-Cell Adult Acute Lymphocytic Leukemia
National Cancer Institute (NCI)P2CCC (53)
Tacrolimus
T-Cell Adult Acute Lymphocytic Leukemia
National Cancer Institute (NCI)P2CCC (53)
Talazoparib
Adrenal Gland Pheochromocytoma
National Cancer Institute (NCI)P2CCC (53)
Talazoparib
Hematopoietic And Lymphoid System Neoplasm
National Cancer Institute (NCI)P2CCC (53)
Talazoparib
HER2 Positive Breast Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Talazoparib
Gastric Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Talazoparib
Exocrine Pancreatic Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Talazoparib
Gastric Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Talazoparib
Paraganglioma
National Cancer Institute (NCI)P2CCC (53)
Tazemetostat
Histiocytic Sarcoma
National Cancer Institute (NCI)P2CCC (53)
Tazemetostat
Juvenile Xanthogranuloma
National Cancer Institute (NCI)P2CCC (53)
Tazemetostat
Endometrial Endometrioid Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Tazemetostat
Uterine Corpus Cancer
National Cancer Institute (NCI)P2CCC (53)
Tazemetostat
Ovarian Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Showing 2051 to 2075 of 3,272 assets
PreviousPage 83 of 131Next